Butyrate, a short-chain fatty acid produced by microbiota, might improve type 2 diabetes features by increasing glucagon-like peptide-1 (GLP-1), an incretin hormone that participates in glucose homeostasis recovering fasting glycemia, insulin resistance, and inflammation49. The gene discussed is INS; the disease is type 2 diabetes mellitus.